Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Mr. Shawn M. CrossCFO | -12,94k | 112,72k | Derivative Exercise and Sale | 16,45 - 25,16 | 105,34k | - |
| 2026-04-20 | Mr. Shawn M. CrossCFO | -12,06k | 104,23k | Derivative Exercise and Sale | 16,45 - 25,14 | 105,34k | - |
| 2026-03-17 | Dr. Jonathan SloninChief Medical Officer | -3,26k | 74,42k | Automatic Disposition | 22,82 | 51,34k | -5,97% |
| 2026-03-17 | Dr. Mark I. FroimsonIndependent Director | -500,00 | 10,91k | Vendita | 21,81 | 13,97k | -3,45% |
| 2026-02-02 | Ms. Kristen M. DunkerInsider | -13,14k | 269,70k | Automatic Disposition | 20,53 | 131,30k | -9,10% |
| 2026-01-30 | Ms. Kristen M. DunkerInsider | -17,13k | 351,93k | Sale to Issuer | 20,54 | 131,30k | -11,54% |
| 2026-01-30 | Mr. Frank D. LeeCEO & Director | -41,49k | 852,16k | Sale to Issuer | 20,54 | 86,75k | -32,35% |
| 2026-01-30 | Mr. Brendan P. TeehanChief Commercial Officer | -5,18k | 106,44k | Sale to Issuer | 20,54 | 8,72k | -37,28% |
| 2026-01-30 | Dr. Jonathan SloninChief Medical Officer | -6,17k | 126,69k | Sale to Issuer | 20,54 | 50,33k | -10,92% |
| 2026-02-02 | Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance | -4,00k | 83,24k | Automatic Disposition | 20,81 | 6,88k | -36,76% |
| 2026-01-30 | Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance | -2,75k | 56,51k | Sale to Issuer | 20,54 | 6,88k | -28,56% |
| 2026-01-05 | Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance | -1,42k | 34,32k | Automatic Disposition | 24,24 | 5,98k | -19,14% |
| 2026-01-02 | Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance | -159,00 | 3,89k | Sale to Issuer | 24,46 | 5,98k | -2,59% |
| 2026-01-02 | Mr. Frank D. LeeCEO & Director | -9,27k | 226,79k | Sale to Issuer | 24,46 | 40,74k | -18,54% |
| 2026-01-02 | Dr. Jonathan SloninChief Medical Officer | -381,00 | 9,32k | Sale to Issuer | 24,46 | 34,01k | -1,11% |
| 2025-12-09 | Mr. Shawn M. CrossCFO | -25,00k | 215,50k | Derivative Exercise and Sale | 16,45 - 25,14 | 56,25k | - |
| 2025-11-17 | Dr. Jonathan SloninChief Medical Officer | -3,96k | 95,40k | Automatic Disposition | 24,09 | 32,61k | -10,83% |
| 2025-11-10 | Mr. Shawn M. CrossCFO | -12,06k | 266,41k | Automatic Disposition | 22,09 | 0,00 | -100,00% |
| 2025-10-06 | John Templeton FoundationSocietà | 76,47k | 1,82M | Acquisto | 23,77 | 812,02k | 10,40% |
| 2025-09-10 | DOMA Perpetual Capital Management, LLCSocietà | 161,71k | 4,29M | Acquisto | 26,50 | 1,97M | 8,96% |
| 2025-10-31 | Mr. Shawn M. CrossCFO | -6,69k | 143,03k | Sale to Issuer | 21,38 | 12,06k | -35,68% |
| 2025-09-04 | Mr. Abraham N. CeesayIndependent Director | -2,35k | 64,01k | Automatic Disposition | 27,19 | 2,88k | -45,01% |
| 2025-08-07 | Dr. Marcelo BigalIndependent Director | -4,91k | 116,27k | Vendita | 23,67 | 5,23k | -48,43% |
| 2025-08-01 | John Templeton FoundationSocietà | 735,55k | 16,31M | Acquisto | 21,78 - 22,77 | 735,55k | - |
| 2025-08-01 | Dr. Jonathan SloninChief Medical Officer | -315,00 | 6,95k | Sale to Issuer | 22,07 | 36,57k | -0,85% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
